Theriva Biologics, Inc. (TOVX) › Total LiabilitiesTheriva Biologics, Inc. (TOVX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $532.0K2011: $417.0K2012: $395.0K2013: $1.03M2014: $9.59M2015: $15.84M2016: $20.25M2017: $10.20M2018: $3.69M2019: $5.75M2020: $3.15M2021: $4.96M2022: $17.30M2023: $15.52M2024: $16.29M2025: $22.86M$22.86M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$22.86M+40.4%2024$16.29M+4.9%2023$15.52M-10.3%2022$17.30M+248.9%2021$4.96M+57.3%2020$3.15M-45.2%2019$5.75M+55.9%2018$3.69M-63.8%2017$10.20M-49.7%2016$20.25M+27.8%2015$15.84M+65.2%2014$9.59M+833.6%2013$1.03M+160.0%2012$395.0K-5.3%2011$417.0K-21.6%2010$532.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share